Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Navidea Biopharmaceuticals Inc (NAVB)

Navidea Biopharmaceuticals Inc (NAVB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 67,898
  • Shares Outstanding, K 26,317
  • Annual Sales, $ 660 K
  • Annual Income, $ -10,950 K
  • 60-Month Beta 1.93
  • Price/Sales 107.19
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade NAVB with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate -0.08
  • Number of Estimates 1
  • High Estimate -0.08
  • Low Estimate -0.08
  • Prior Year -0.17
  • Growth Rate Est. (year over year) +52.94%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.41 +7.51%
on 09/30/20
2.99 -13.34%
on 09/21/20
-0.35 (-11.87%)
since 09/18/20
3-Month
2.41 +7.51%
on 09/30/20
5.36 -51.63%
on 07/21/20
-2.28 (-46.80%)
since 07/20/20
52-Week
0.63 +311.27%
on 04/16/20
5.36 -51.63%
on 07/21/20
+1.79 (+223.88%)
since 10/18/19

Most Recent Stories

More News
Navidea Biopharmaceuticals Announces Acceptance of Abstract for Presentation at the American College of Rheumatology Annual Meeting

Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced that...

NAVB : 2.61 (+1.16%)
Navidea Biopharmaceuticals to Ring Opening Bell at the New York Stock Exchange

Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced that...

NAVB : 2.61 (+1.16%)
Navidea Biopharmaceuticals to Present at H.C. Wainwright 22nd Annual Global Investment Conference

Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced that...

NAVB : 2.61 (+1.16%)
Navidea Biopharmaceuticals Wins Dismissal of Platinum Loan Litigation

Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, is pleased to announce...

NAVB : 2.61 (+1.16%)
Navidea Biopharmaceuticals to Present at The LD 500 Virtual Investor Conference

Navidea Biopharmaceuticals, Inc. (NYSE American:NAVB) ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced that...

NAVB : 2.61 (+1.16%)
Navidea Biopharmaceuticals Reports Second Quarter and Year-to-Date 2020 Financial Results

Navidea Biopharmaceuticals, Inc. (NYSE American:NAVB) ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced its...

NAVB : 2.61 (+1.16%)
Thinking about buying stock in Navidea Biopharmaceuticals, CleanSpark Inc, Aerpio Pharmaceuticals, Hertz Global Holdings, or Walt Disney?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NAVB, CLSK, ARPO, HTZ, and DIS.

ARPO : 1.3700 (+0.74%)
CLSK : 9.15 (-1.19%)
HTZ : 2.19 (+0.92%)
NAVB : 2.61 (+1.16%)
DIS : 125.00 (+0.62%)
Navidea Biopharmaceuticals Signs Binding Framework for Commercialization Partnership with Jubilant Radiopharma

Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, is pleased to announce...

NAVB : 2.61 (+1.16%)
Navidea Biopharmaceuticals to Host Second Quarter 2020 Earnings Conference Call and Corporate Update

Navidea Biopharmaceuticals, Inc. (NYSE American:NAVB) ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced it...

NAVB : 2.61 (+1.16%)
Is the Options Market Predicting a Spike in Navidea Biopharmaceuticals (NAVB) Stock?

Investors need to pay close attention to Navidea Biopharmaceuticals (NAVB) stock based on the movements in the options market lately.

NAVB : 2.61 (+1.16%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Navidea Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agents for diseases such as cancer and Alzheimer. The Company's radiopharmaceutical development programs include: Lymphoseek(R), AZD4694 and...

See More

Key Turning Points

2nd Resistance Point 2.76
1st Resistance Point 2.67
Last Price 2.61
1st Support Level 2.52
2nd Support Level 2.46

See More

52-Week High 5.36
Fibonacci 61.8% 3.55
Fibonacci 50% 2.99
Last Price 2.61
Fibonacci 38.2% 2.44
52-Week Low 0.63

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar